| Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition S Zhao, S Bellone, S Lopez, D Thakral, C Schwab, DP English, J Black, ... Proceedings of the National Academy of Sciences 113 (43), 12238-12243, 2016 | 204 | 2016 |
| Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma TL Mao, L Ardighieri, A Ayhan, KT Kuo, CH Wu, TL Wang, IM Shih The American journal of surgical pathology 37 (9), 1342-1348, 2013 | 104 | 2013 |
| FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients RA Tassi, P Todeschini, ER Siegel, S Calza, P Cappella, L Ardighieri, ... Journal of Experimental & Clinical Cancer Research 36, 1-18, 2017 | 72 | 2017 |
| Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants L Ardighieri, F Zeppernick, CG Hannibal, R Vang, L Cope, J Junge, ... The Journal of pathology 232 (1), 16-22, 2014 | 70 | 2014 |
| Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy L Zammataro, S Lopez, S Bellone, F Pettinella, E Bonazzoli, E Perrone, ... Proceedings of the National Academy of Sciences 116 (45), 22730-22736, 2019 | 66 | 2019 |
| BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors F Zeppernick, L Ardighieri, CG Hannibal, R Vang, J Junge, SK Kjaer, ... The American journal of surgical pathology 38 (12), 1603-1611, 2014 | 62 | 2014 |
| Integrated mutational landscape analysis of uterine leiomyosarcomas J Choi, A Manzano, W Dong, S Bellone, E Bonazzoli, L Zammataro, X Yao, ... Proceedings of the National Academy of Sciences 118 (15), e2025182118, 2021 | 60 | 2021 |
| Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors C Li, E Bonazzoli, S Bellone, J Choi, W Dong, G Menderes, G Altwerger, ... Proceedings of the National Academy of Sciences 116 (2), 619-624, 2019 | 54 | 2019 |
| Characterization of the immune cell repertoire in the normal fallopian tube L Ardighieri, S Lonardi, D Moratto, F Facchetti, IM Shih, W Vermi, ... International Journal of Gynecological Pathology 33 (6), 581-591, 2014 | 46 | 2014 |
| Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma L Lorini, L Ardighieri, A Bozzola, C Romani, E Bignotti, M Buglione, ... Oral oncology 115, 105213, 2021 | 42 | 2021 |
| Infiltration by CXCL10 secreting macrophages is associated with antitumor immunity and response to therapy in ovarian cancer subtypes L Ardighieri, F Missale, M Bugatti, LB Gatta, I Pezzali, M Monti, S Gottardi, ... Frontiers in immunology 12, 690201, 2021 | 36 | 2021 |
| Molecular profiling of salivary oncocytic mucoepidermoid carcinomas helps to resolve differential diagnostic dilemma with low-grade oncocytic lesions A Skálová, A Agaimy, O Stanowska, M Baneckova, N Ptáková, ... The American Journal of Surgical Pathology 44 (12), 1612-1622, 2020 | 34 | 2020 |
| Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: The role of perineural invasion in recurrence and survival F Ferrari, S Forte, L Ardighieri, E Bonetti, B Fernando, E Sartori, F Odicino European Journal of Surgical Oncology 45 (11), 2115-2119, 2019 | 34 | 2019 |
| Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy S Bellone, R Tassi, M Betti, D English, E Cocco, S Gasparrini, I Bortolomai, ... British journal of cancer 109 (2), 462-471, 2013 | 32 | 2013 |
| Current treatment options for cervical leiomyomas: a systematic review of literature F Ferrari, S Forte, G Valenti, L Ardighieri, F Barra, V Esposito, E Sartori, ... Medicina 57 (2), 92, 2021 | 29 | 2021 |
| Endometrial carcinomas with intestinal-type metaplasia/differentiation: does mismatch repair system defects matter? Case report and systematic review of the literature L Ardighieri, A Palicelli, F Ferrari, M Bugatti, E Drera, E Sartori, F Odicino Journal of Clinical Medicine 9 (8), 2552, 2020 | 27 | 2020 |
| Disseminated histoplasmosis as AIDS-presentation. Case report and comprehensive review of current literature P Zanotti, C Chirico, M Gulletta, L Ardighieri, S Casari, EQ Roldan, I Izzo, ... Mediterranean journal of hematology and infectious diseases 10 (1), 2018 | 25 | 2018 |
| Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship L Ardighieri, L Mori, S Conzadori, M Bugatti, M Falchetti, CM Donzelli, ... Virchows Archiv 469, 61-69, 2016 | 25 | 2016 |
| FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients RA Tassi, A Gambino, L Ardighieri, E Bignotti, P Todeschini, C Romani, ... British Journal of Cancer 121 (7), 584-592, 2019 | 24 | 2019 |
| A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment E Calura, L Paracchini, R Fruscio, A DiFeo, A Ravaggi, J Peronne, ... Annals of Oncology 27 (8), 1511-1519, 2016 | 24 | 2016 |
